A Focal Lesion in the Falx Cerebri: Harbinger of Classic Stage 4 Neuroblastoma in an Infant Cured Despite Residual Disease After Minimal Therapy

Overview

Journal Pediatr Blood Cancer

Specialties Hematology
Oncology
Pediatrics

Date 2009 Aug 28

PMID 19711437

Authors

Brian H Kushner

Kim Kramer

Shakeel Modak

Timothy J Akhurst

Nai-Kong V Cheung

Affiliations

Soon will be listed here.

Abstract

An asymptomatic 11-week-old male received no treatment after he was classified as having a suspected atypical form of MYCN-nonamplified hyperdiploid stage 4S neuroblastoma (NB), with masses in an adrenal gland, subcutaneous tissues, and the falx cerebri. Within 2 months, however, disease progressed in dura and bone marrow. Two cycles of low-dose chemotherapy achieved a partial response; treatment was discontinued. Complete remission was documented 24 weeks post-cycle 2, and has continued >6 years. The falx cerebri probably does not represent an atypical site for stage 4S NB, but stage 4 NB with favorable biology is sometimes curable with minimal therapy.

References

Nuchtern J . Perinatal neuroblastoma. Semin Pediatr Surg. 2006; 15(1):10-6. DOI: 10.1053/j.sempedsurg.2005.11.003. View

Simon T, Spitz R, Faldum A, Hero B, Berthold F . New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. J Pediatr Hematol Oncol. 2004; 26(12):791-6. View

Nickerson H, Matthay K, Seeger R, Brodeur G, Shimada H, Perez C . Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol. 2000; 18(3):477-86. DOI: 10.1200/JCO.2000.18.3.477. View

Schleiermacher G, Rubie H, Hartmann O, Bergeron C, Chastagner P, Mechinaud F . Treatment of stage 4s neuroblastoma--report of 10 years' experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer. 2003; 89(3):470-6. PMC: 2394373. DOI: 10.1038/sj.bjc.6601154. View

Schmidt M, Lal A, Seeger R, Maris J, Shimada H, OLeary M . Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. J Clin Oncol. 2005; 23(27):6474-80. DOI: 10.1200/JCO.2005.05.183. View

Nishio N, Mimaya J, Horikoshi Y, Okada N, Nara T, Takashima Y . Spontaneous regression of metastases including meningeal metastasis after gross resection of primary tumor in an infant with stage 4 neuroblastoma. J Pediatr Hematol Oncol. 2006; 28(8):537-9. DOI: 10.1097/01.mph.0000212970.06125.8e. View

Hero B, Simon T, Horz S, Berthold F . Metastatic neuroblastoma in infancy: what does the pattern of metastases contribute to prognosis?. Med Pediatr Oncol. 2000; 35(6):683-7. DOI: 10.1002/1096-911x(20001201)35:6<683::aid-mpo43>3.0.co;2-f. View

Pritchard J, Hickman J . Why does stage 4s neuroblastoma regress spontaneously?. Lancet. 1994; 344(8926):869-70. DOI: 10.1016/s0140-6736(94)92834-7. View

Brunetti A, Tedeschi E, Belfiore G, Salvatore M . [Neuroblastoma metastasis to the falx cerebri. A case report]. Radiol Med. 1992; 83(4):467-70. View

10.

Kushner B, Kramer K, LaQuaglia M, Modak S, Cheung N . Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients. Pediatr Blood Cancer. 2005; 46(3):278-84. DOI: 10.1002/pbc.20564. View

11.

Shah N, Wilt E, Lobel J, Mahmud F, Cera P . Intracranial neuroblastoma. Med Pediatr Oncol. 1995; 24(4):257-61. DOI: 10.1002/mpo.2950240408. View

12.

Guglielmi M, De Bernardi B, Rizzo A, Federici S, Boglino C, Siracusa F . Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?. J Clin Oncol. 1996; 14(5):1537-44. DOI: 10.1200/JCO.1996.14.5.1537. View

13.

Kramer K, Kushner B, Allen J, Krol G, Cheung N . Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentation. J Pediatr Hematol Oncol. 2004; 26(11):703-5. DOI: 10.1097/00043426-200411000-00003. View

14.

Hufnagel M, Claviez A, Czech N, Schmidt M, Hero B . Neuroblastoma stage 4S with 123I-MIBG-positive bone marrow involvement. Pediatr Blood Cancer. 2005; 46(2):264-5. DOI: 10.1002/pbc.20536. View

15.

George R, London W, Cohn S, Maris J, Kretschmar C, Diller L . Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 2005; 23(27):6466-73. DOI: 10.1200/JCO.2005.05.582. View

16.

Maris J, Hogarty M, Bagatell R, Cohn S . Neuroblastoma. Lancet. 2007; 369(9579):2106-20. DOI: 10.1016/S0140-6736(07)60983-0. View

17.

Schmidt M, Lukens J, Seeger R, Brodeur G, Shimada H, Gerbing R . Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol. 2000; 18(6):1260-8. DOI: 10.1200/JCO.2000.18.6.1260. View

18.

Minard V, Hartmann O, Peyroulet M, Michon J, Coze C, Defachelle A . Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology. Br J Cancer. 2000; 83(8):973-9. PMC: 2363565. DOI: 10.1054/bjoc.2000.1412. View